Global Enteral Feeding Formula Market was valued at USD 6.68 billion in 2020, growing at a CAGR of 1.13% during the forecast period from 2021 to 2026, it is expected to reach USD 10.06 billion by 2026. As per DelveInsight analysis, the Enteral Feeding Formula market is expected to grow in the coming years owing to the rising prevalence of chronic diseases such as cancer, stroke, chronic liver disease, Chronic Obstructive Pulmonary Disease (COPD), and diabetes, the growing burden of the geriatric population, higher premature births, and the growing awareness of enteral nutrition across the globe. Moreover, the accumulative focus on developing technologically advanced devices in the product arena will also contribute to the Global Enteral Feeding Formula Market. Some of the key companies in the Enteral Feeding Formula market include Fresenius Health Care Group, Mead Johnson & Company LLC, Victus, Inc., Global Health Products, Inc., Meiji Holdings Co. Ltd., Ajinomoto Cambrooke Inc., B. Braun Melsungen AG, Baxter, Nestlé S.A., Laborie, Abbott, Dandle LION Medical, Prolacta Bioscience Inc., Kate Farms, Nutricia (Danone S.A.) and others.
DelveInsight’s “Global Enteral Feeding Formula Market Forecast” Report provides the current and forecasted Enteral Feeding Formula Market trends for the next five years, upcoming innovations in the devices, individual market shares, challenges, drivers & barriers, and key competitors in the market.
Enteral Feeding Formula Overview
Enteral Feeding formulas are used in patients that cannot swallow by mouth to provide nutritional supplementation. With the help of these formulas, food can be passed via the gastrointestinal tract. Enteral feeding is required by patients suffering from chronic conditions such as gastrointestinal disorders, cancer, among others. Enteral Formulas are interchangeably called by several other terms such as “enteral nutrition formulas” or “peptide-based diets.”
Enteral Feeding Formulas Market By Types of Feeding Formula is segmented as Standard Formula, Disease-Specific Formula, and Others. By patient type, it is segregated as adults and paediatrics. By application type, it is divided into Oncology, Neurology, Pain Management, Diabetes, Nutrition Deficiency, Others).
To provide an in-depth assessment into the market, DelveInsight’s “Enteral Feeding Formula Market” report delivers detailed information into the types of enteral formulas, patient types, applications, end-users, and geography.
The enteral nutrition formulas are segmented as Standard Formula, Disease-Specific Formula, Others. The Standard Formula market segment is expected to hold the major share. The large market share of this product segment is due to the growing patient adoption of these formulas. Standard Formula consists of all the essential nutrients required to maintain proper health conditions. Some Standard Formulas can be used for both enteral feedings and as an oral supplement, and they may also contain added ingredients, such as fibre, for digestive health and bowel management.
Enteral Feeding Formula Market
The Enteral Feeding Formula Market is expected to witness a massive growth in product demand owing to the higher prevalence of chronic diseases such as stroke, chronic liver disease, Chronic Obstructive Pulmonary Disease (COPD), and diabetes. Apart from these, the increasing geriatric population, higher premature births, growing awareness of enteral nutrition, among others, are also expected to drive the demand for the Enteral Formula.
As per WHO (2020), cancer is the leading cause of death worldwide, and in 2020, nearly 10 million lost their lives due to cancer. Similarly, as per Cancer Research UK (2018), the population suffering from cancer is expected to increase significantly in the future, and by 2040 there will be 27.5 million new cancer cases worldwide each year. The rising case of cardiovascular disorders also leads to a high number of deaths globally. As per the data provided by the World Health Organization (2021), cardiovascular disorders affect about 17.9 million lives every year. Furthermore, the World Heart Federation (in 2019) had estimated that more than 23 million lives will be affected owing to cardiovascular disorders by the year 2030.
The patients in ICUs are not comfortable taking food orally. In order to facilitate proper nutrition in patients, it becomes necessary to give the required nutrients through enteral feeding. As the prevalence of chronic disorders, cancer, and diabetes is growing, it is expected to contribute immensely to the growth of the Enteral Feeding Formulas Market.
Another key aspect influencing the Enteral Feeding Formulas Market is the increasing geriatric population base across the globe. As per World Health Organization (in 2020), about one billion people across the world were over the age of 60, and by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 reaching 426 million.
The rising elderly population is expected to lead to the rise in the patient population of enteral formula across the world, which in turn would lead to an increase in the Enteral Feeding Formulas Market growth during the forecast period (2021-2026).
However, certain factors like some patients are allergic and the use of these formulas are associated with severe enteral feeding-related complications risks, resulting in additional risks that may restrict the growth of the Global Enteral Feeding Formulas Market.
Interested to know more about the ongoing developments in the Enteral Feeding Formula Market? Visit to get an in-depth insight into Enteral Feeding Formula – Procedure, Types, and Emerging Products
Enteral Feeding Formula Market Insights
As per DelveInsight, North America is expected to dominate the overall Enteral Feeding Formula Market Size during the forecast period. The major factors contributing to the high market growth include rising trends in premature births and the increasing geriatric population. As per the Centers for Disease Control and Prevention 2019, preterm birth affected 1 of every 10 infants born in the United States. Moreover, according to National Health Interview Survey (NHIS) (2018), more than half (51.8%) of adults had at least 1 of 10 selected diagnosed chronic conditions, and 27.2% of US adults had multiple chronic conditions. As per the American Heart Association 2021, in the year 2019 cardiovascular disorders were the leading cause of death in the United States and coronary heart disease had accounted for about 42.1% of the deaths attributable to CVD in the United States.
Additionally, factors such as high disposable income, technological advancements in product developments, sophisticated healthcare infrastructure, new product approvals, and increased awareness are also expected to influence the Enteral Feeding Formulas Market growth in this region. Overall, the rising adoption of the Enteral Formula in the country would result in the rising demand for treatments that make use of Enteral Feeding Formula, which in turn would provide a conducive growth environment for the North America Enteral Feeding Formula market.
Rising product development activities, the high interest of manufacturers in accessing local markets, the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region provides an edge to the North America region over other regions in the Enteral Feeding Formula Market.
Interested in knowing how the Enteral Feeding Formula Market will be growing by 2026? Click to get a snapshot @ Enteral Feeding Formula Market Trends and Developments
Enteral Feeding Formula Market – Recent Breakthroughs & key Innovations
Over the years, the Enteral Feeding Formula Market has evolved immensely due to the technological advancement and the active participation of the global players in the domain.
Here are a few of the major Breakthroughs & key Innovations in the Enteral Feeding Formulas Market –
- On March 16, 2021, Kate Farms® announced its three newest products are eligible for insurance coverage for Medi-Cal beneficiaries effective January 1, 2021. The company’s latest formula innovations – Kate Farms Pediatric Peptide 1.0 Vanilla and Kate Farms Standard 1.4 Vanilla and Plain – were listed in the approved Medi-Cal Rx List of Enteral Nutrition Products for children and adult recipients.
- On Aug. 24, 2020, Kate Farms® announced the launch of two new organic, plant-based products – Kate Farms Standard 1.4 formula and Kate Farms Pediatric Peptide 1.0 formula.
- On December 20, 2019, LABORIE Medical Technologies, announced the acquisition of Clinical Innovations for an enterprise value of USD 525 million. Clinical Innovations was a leading global provider of clinician-preferred medical devices for the labour & delivery (L&D) and neonatal intensive care unit (NICU) specialities and was actively involved in child nutrition.
As per DelveInsight, the ongoing clinical and commercial developments will contribute immensely to the Enteral Feeding Formula Market Growth in the coming years.
Key Players In the Enteral Feeding Formula Market
Some of the key companies operating in the Global Enteral Feeding Formula Market are Fresenius Health Care Group (ETR: FME), Mead Johnson & Company LLC (NYSE: MJN), Victus, Inc., Global Health Products, Inc., Meiji Holdings Co. Ltd. (TYO: 2269), Ajinomoto Cambrooke Inc., B. Braun Melsungen AG, Baxter (NYSE: BAX), Nestlé S.A. (SWX: NESN), Laborie, Abbott (NYSE: ABT), Dandle LION Medical, Prolacta Bioscience Inc., Kate Farms, Nutricia (Danone S.A.) (EPA: BN), among others. Due to the very high growth rate and positive return, several new players are expected to enter the Enteral Feeding Formula Market, making it one of the most competitive domains in the healthcare sector.
Learn how new players’ entries will transform the Enteral Feeding Formula Market in the coming years @ Enteral Feeding Formula’ Competitive Landscape.
Covid-19 Impact on Enteral Feeding Formula Market
Globally, the outbreak of the COVID-19 pandemic had a profound impact across various industries. During the pandemic, many patients required a home Enteral Feeding Formula for the care of their nutritional requirements. As per the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, Gastric Enteral Nutrition is advised for severe COVID-19 patients and should be preferably performed using a pump with a flow regulator, within 48 hours of admission to the ICU.
The significant number of COVID cases has led to the patient being more dependent on Enteral Formula. Due to this, there was substantial growth in the Enteral Feeding Formula Market globally. The Enteral Feeding Formula market also observed a massive increase in growth. Despite the reduction in Covid-19 cases and the increase in the vaccination, the Enteral Feeding Formula Market is expected to depict healthy growth in the coming years as well owing to factors such as the rising number of cancer cases, among others.
To gain a better understanding of potential new entrants in the market, competitive dynamics, and attractiveness of the Enteral Feeding Formula Market market, connect with us to get Enteral Feeding Formula Porter’s Five Forces Analysis
Scope of the Enteral Feeding Formula Market Report:
- Geography Covered: Global
- Study Period: 2021-2026
- Enteral Feeding Formula Market by Types of Feeding Formula – Standard Formula, Disease-Specific Formula, Others
- By Patient Type – Adults and Pediatrics
- By Application – Oncology, Neurology, Pain Management, Diabetes, Nutrition Deficiency, and Others
- By End-User – Hospitals, Homecare, Others
- By Geography – North America, Europe, Asia-Pacific, and Rest of the World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Table of Contents
|3||Regulatory and Patent Analysis|
|4||Enteral Feeding Formula Market Key factors analysis|
|5||Enteral Feeding Formula Porter’s Five Forces Analysis|
|6||COVID-19 Impact Analysis on Enteral Feeding Formula Market|
|7||Enteral Feeding Formula Market Layout|
|8||Enteral Feeding Formula Global Company Share Analysis – Key 3-5 Companies|
|9||Enteral Feeding Formula Product Profiles and Key Companies|
Reach out to us to get a more detailed overview of the Enteral Feeding Formula Regulatory & Patent Analysis.
Key Takeaways From the Enteral Feeding Formula Market Report Study
- In-depth analysis of the Enteral Feeding Formula Market size, share, and key trends.
- Comprehensive analysis for current Enteral Feeding Formula Market size (2020), and market forecast for 5 years (2021-2026)
- The effect of the COVID-19 pandemic on the Enteral Feeding Formula Market is significant. To capture and analyze suitable indicators, our experts are closely watching the Enteral Feeding Formula Market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Enteral Feeding Formula Market.
- Various opportunities are available for the other competitors in the Enteral Feeding Formula Market space.
- What are the top-performing segments in 2020? How these segments will perform in 2026.
- Which are the top-performing regions and countries in the current Enteral Feeding Formula Market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Enteral Feeding Formula market growth in the coming future?
Related Healthcare Reports by DelveInsight
Trending Healthcare Blogs by DelveInsight
- Intratumoral Cancer Therapy
- Rare Cancer Market
- Small Cell Lung Cancer Treatment Market
- Leading Liquid Biopsy Companies Impacting Cancer Diagnostics Market
- Novel and Emerging Metastatic Colorectal Cancer Treatment Drugs
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Get in touch with our team to get more detailed insights how the MedTech Market is expected to evolve in the coming years and to formulate innovative business solutions at MedTech Consulting Solutions